GENEVA,2nd December, 2024 (WAM) - World Intellectual Property Organisation's international patent system published its 5 millionth patent application, marking a major milestone in decades of ...
Casgevy was the first drug to be licensed based on CRISPR, which earned its discoverers a Nobel Prize in 2020. The one-shot therapy is an ex vivo application of the technology, meaning that bone ...
CRISPR-Cas systems are prokaryotic immune systems ... Red light optogenetic systems are in high demand for therapeutic applications. Here, the authors introduce REDLIP, a red-light-inducible ...
CRISPR-Cas9 genome editing exploits the CRISPR ... Red light optogenetic systems are in high demand for therapeutic applications. Here, the authors introduce REDLIP, a red-light-inducible system ...
The complexity of the central nervous system (CNS) and its pathologies necessitates an intricate understanding of the cellular and molecular mechanisms at play. Single-cell biology has emerged as a ...
The world of health devices and therapy is evolving faster than ever and 2024 is shaping up to be a groundbreaking year From wearable tech that monitors your vitals in real time to cutting-edge therap ...